NOT-NR-22-012: Notice of Clarification of Research Priorities for RFA-NR-22-002, "Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Required)"

Notice of Clarification of Research Priorities for RFA-NR-22-002, "Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Required)"

Notice Number:

NOT-NR-22-012

Key Dates

Release Date:

March 8, 2022

Related Announcements

RFA-NR-22-002 - Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Required)

Issued by

National Institute of Nursing Research (NINR)

Purpose

The purpose of this Notice is to inform the applicant community of an expansion in the severe maternal morbidity primary outcomes of interest for RFA-NR-22-002. Documented state-level severe maternal morbidity indicators and other conditions that increase the risk of severe maternal morbidity and mortality in the antepartum, intrapartum, and postpartum periods (e.g., hypertensive disorders of pregnancy, hemorrhage) are of interest as primary outcomes in addition to the Centers for Disease Control and Prevention indicators as outlined in the funding opportunity. Composite outcomes that combine two or more indicators and/or conditions are also of interest.

Inquiries

Please direct all inquiries to:

Shalanda A. Bynum, PhD, MPH
National Institute of Nursing Research (NINR)
Telephone: 301-755-4355
Email: shalanda.bynum@nih.gov